FailedDiscontinued

AMT-162

Amyotrophic lateral sclerosis

QUREUniqure NV

Expected catalystTBA

Catalyst overview

Event details

Drug or asset: AMT-162
Development stage: Failed
Event type: Discontinued
Indication: Amyotrophic lateral sclerosis

Research summary

What is being tracked?

This catalyst tracks a Failed discontinued for AMT-162 in Amyotrophic lateral sclerosis. The expected timing is based on the latest available company guidance and may change.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source

FailedDiscontinued

AMT-162

Amyotrophic lateral sclerosis

QUREUniqure NV

Expected catalystTBA

Catalyst overview

Event details

Drug or asset: AMT-162
Development stage: Failed
Event type: Discontinued
Indication: Amyotrophic lateral sclerosis

Research summary

What is being tracked?

This catalyst tracks a Failed discontinued for AMT-162 in Amyotrophic lateral sclerosis. The expected timing is based on the latest available company guidance and may change.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source

AMT-162

Event details

What is being tracked?

Primary source

Related pipeline programs

AMT-260

AMT-191

AMT-162

Event details

What is being tracked?

Primary source

Related pipeline programs

AMT-260

AMT-191